Brief: Kineta entered into an option and license agreement with GigaGen
15/12/2023 14:10
Dec 15 (Reuters) - Kineta Inc KA.O :
* KINETA INC - ON DECEMBER 14, 2023, CO, GIGAGEN ENTERED
INTO THE
FOURTH AMENDMENT TO OPTION AND LICENSE AGREEMENT
* KINETA INC - EXTEND THE END OF THE OPTION TERM UNDER THE
CD27
AGREEMENT FROM DECEMBER 31, 2023 TO FEBRUARY 1, 2024
Source text for Eikon: [https://bitly.ws/369Ft]
Further company coverage: KA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kineta
See all newsBrief: TuHURA Biosciences And Kineta Stockholders Approve Proposed Merger And All Related Proposals
Brief: Kineta Updates KVA12123 Clinical Results From Ongoing Phase 1/2 Vista101 Study At Society For Immunotherapy Of Cancer
U.S. STOCKS ON THE MOVE-Copper miners, Palo Alto Networks, Lowe's
U.S. STOCKS ON THE MOVE-Lineage, J.B. Hunt, McDonald's
Kineta rises on resuming enrollment in early-stage cancer study